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Turnover in Human Tendon
Stem/Progenitor Cells
Cvetan Popov, Julia Kohler and Denitsa Docheva*
Experimental Surgery and Regenerative Medicine, Department of Surgery, Ludwig Maximilians University, Munich, Germany
Tendon tissues, due to their composition and function, are prone to suffer age-related
degeneration and diseases as well as to respond poorly to current repair strategies. It
has been suggested that local stem cells, named tendon stem/progenitor cells (TSPCs),
play essential roles in tendon maintenance and healing. Recently, we have shown
that TSPC exhibit a distinct age-related phenotype involving transcriptomal shift, poor
self-renewal, and elevated senescence coupled with reduced cell migration and actin
dynamics. Here, we report for the first time the significant downregulation of the ephrin
receptors EphA4, EphB2 and B4 and ligands EFNB1 in aged-TSPC (A-TSPC). Rescue
experiments, by delivery of target-specific clustered proteins, revealed that activation of
EphA4- or EphB2-dependent reverse signaling could restore the migratory ability and
normalize the actin turnover of A-TSPC. However, only EphA4-Fc stimulation improved
A-TSPC cell proliferation to levels comparable to young-TSPC (Y-TSPC). Hence, our
novel data suggests that decreased expression of ephrin receptors during tendon aging
and degeneration limits the establishment of appropriate cell-cell interactions between
TSPC and significantly diminished their proliferation, motility, and actin turnover. Taken
together, we could propose that this mechanism might be contributing to the inferior
and delayed tendon healing common for aged individuals.
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INTRODUCTION
Tendon injuries due to excessive mechanical stress or tissue aging and/or degeneration are
common and present a significant challenge for orthopedic surgery. Aged and/or degenerated
tendons respond poorly to classical medicinal treatments, which often leads to rupture
reoccurrence. Until now, several major factors contributing, directly, or indirectly, to tendon aging
and degeneration were identified: disturbance of extracellular matrix turnover; decreasing cell
numbers and metabolic activity; tenocyte dedifferentiation; and depletion or senescence of the
local stem/progenitor cell pool (Jozsa and Kannus, 1997; Kaeding and Best, 2009; Zhou et al., 2010;
Kohler et al., 2013).
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Tendon stem/progenitor cells (TSPCs) were first reported in
(Bi et al., 2007) as plastic adherent cells that possess strong
clonogenic potential and express classical stem cell markers,
while maintaining the expression of typical tendon-lineage genes,
such as Scleraxis and tenomodulin (Bi et al., 2007; Kohler
et al., 2013). Additionally, these cells are able to differentiate to
three different lineages in vitro and more importantly, can form
tendon-like tissue in vivo (Bi et al., 2007). In the same year, by
using chimeric tendon-GFP rat models, (Kajikawa et al., 2007)
proposed that tendon healing is carried out mainly by such local
tendon progenitor cells, which actively migrate to the wound
site and engage in cell proliferation. However, others and we
have found that TSPC features alter during tendon aging and
degeneration (Zhou et al., 2010; Kohler et al., 2013). Aged TSPC
(A-TSPC) display a profound self-renewal deficit accompanied
with premature entry into senescence and substantial changes in
their transcriptome, especially in genes regulating cell adhesion,
migration and cytoskeleton, but unaltered multipotential (Kohler
et al., 2013). Furthermore these cells exhibit severely dysregulated
cell–matrix interactions, motility and actin dynamics (Kohler
et al., 2013).
In recent years, the role of ephrins and their signaling in
regulating numerous cellular processes has been recognized in
different cell types and tissues. Ephrins are receptor tyrosine
kinases that mediate short-range cell-cell communication. For
their activation, a binding between the membrane-bound ephrin
receptor (Eph) and ephrin ligand (EFN) located on the surface of
the neighboring cell is required. There are 9 EphA and 5 EphB
receptors, and 5 EFNA and 3 EFNB ligands expressed in humans.
Typically, EphA receptors bind to EFNA ligands and EphB
receptors bind to EFNB ligands; however, EphA4 and EphB1
receptors can bind to both EFNA and EFNB ligands (Egea and
Klein, 2007). Eph-EFN bond initiate simultaneously bidirectional
signaling in the receptors (forward) and ligands (reverse)
expressing cells that can activate key cellular kinases, such as focal
adhesion kinase (FAK), extracellular signal-regulated kinases
(ERK), Akt, c-Jun N-terminal kinases (JNKs) and p38 mitogen-
activated protein kinases (p38), and thereon can influence cell
self-renewal, migration, and actin turnover (Murai and Pasquale,
2003; Pasquale, 2010; Arthur et al., 2011).
Ephrin receptor-ligand interactions and their diverse roles
have been the best studied in neuronal and cancerous
cells (Genander and Frisen, 2010). Ephrins were linked to
regeneration of the central neuronal system due their functions
in neuronal connections and axon guidance (Du et al., 2007).
Certain ephrin members have been associated with cancer cell
migration and tumor progression (Guo et al., 2006).
Few studies have also elaborated on the role for ephrins and
their signaling in musculoskeletal tissues. For example in bone,
ephrins can positively influence osteoblast differentiation (Zhao
et al., 2006; Xing et al., 2010), but suppress osteoclastogenesis
by affecting TRAP, cathepsin K and integrin β3 signaling (Zhao
et al., 2006; Cheng et al., 2012; Stiffel et al., 2014). In muscle
development, ephrin interactions are required for the appropriate
formation of neuromuscular junctions, nerve branching and
topographic innervation within individual muscles, as well as
for myoblast directed migration to the dorsal and ventral limb
muscles (Swartz et al., 2001; Stark et al., 2011). Interestingly,
it has been found that ephrins can also affect the functions
of tissue-resident stem cells. Arthur et al. (2011) reported that
activation of EFNB1 and EFNB2 reverse signaling inhibit the
attachment and spreading of bone-marrow mesenchymal stem
cells, while stimulation of EphB2 and EphB4 forward signaling
promotes their migration. Goichberg et al. (2011) and Li and
Johnson (2013) showed that EphA2/EFNA1 and EFNA5 can
enhance the migration of human and bovine cardiac stem cells,
correspondingly. In a follow up study, Goichberg et al. (2013)
found that disturbed EphA2/EFNA1 signaling is related to age-
associated senescence and reduced migration of human cardiac
progenitor cells, and demonstrated that overexpression of EphA2
in these cells can rescue their senescent andmigratory phenotype.
Despite of the broader knowledge in other tissues, up-to-date
ephrin family expression and functions in tendon tissues and
cells essentially remain unknown. Only one developmental paper,
based on in situ hybridization analyses, has reported during
embryonal chick development a strong EphA4 expression within
the tendon core (D’Souza and Patel, 1999). Interestingly, our
previous microarray data suggested differential expression levels
of several ephrin members in A-TSPC in comparison to the
control young-TSPC (Y-TSPC; Kohler et al., 2013).
Cumulatively, this strongly motivated us to examine for the
first time the expression pattern of this neglected family in
TSPC. Our main aims in this study were: (i) to characterize
the ephrin expression profile of TSPC in vitro; (ii) to identify
key candidates among the expressed ephrin members that are
dysregulated in A-TSPC versus Y-TSPC; and (iii) to investigate
if the selected ephrin members can contribute to restoring their
aging phenotype.
MATERIALS AND METHODS
Cell Isolation and Culture
The isolation and complete characterization of human Y- and
A-TSPC was reported in Kohler et al. (2013, under Ethical
grant No. 166-08 LMU Medical Faculty). In brief, TSPC were
obtained from non-ruptured Achilles tendons from four young
and 12 elder human donors as tendon tissue biopsies were
minced into small pieces, enzymatically digested with 0.15%
collagenase II (Worthington, USA) in culture medium at 37◦C
overnight, filtered with sterile nylon mesh (100 μm pore size)
and centrifuged at 500 g for 10 min. Then, cell pellets were
suspended and expanded in DMEM/Ham’s F-12 (1:1 mixture)
supplemented with stabile glutamine, 1× MEM amino acids
(all from Merck Millipore, USA), 10% FBS, and 1% L-ascorbic
acid-2-phosphate (both from Sigma–Aldrich, Germany), and the
TSPC were cultivated in a humidified incubator at constant 37◦C
and 5% CO2. During the initial cultivation, all individual cell
lines were monitored for cell yield, morphology and expansion
kinetics. Since within each group, the cell lines were very
comparable, equal group size of three representative donor-
derived TSPC were formed in order to carry out in-depth
ephrin analyses. All experiments were performed with TSPC at
passages 4–6.
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Activation of ephrin-dependent signaling in A-TSPC was
done based on (Kaneko and Nighorn, 2003; Arthur et al.,
2011) protocol with minor modifications. First, 1 μg/ml
recombinant human ephrin-Fc chimera (EphA4, EphB2, EphB4,
and EFNB1-Fc, all R&D systems, USA) or control-Fc proteins
were clustered with polyclonal anti-human Fc antibody (molar
ratio 5:1, Dianova, Germany) in complete culture media at
room temperature for 30 min. Then, A-TSPC were harvested
from tissue culture dishes, counted, resuspended, and incubated
in ephrin-Fc or Fc-control media for 30 min in humidified
incubator. Thereafter, cells were plated for various experiments
and the treated A-TSPC were supplemented every second day
with fresh media, containing 1μg/ml clustered ephrin-Fc and Fc-
control. In each experiment, Y-TSPC at the same passage number
was used as positive control.
Quantitative PCR Analysis
RNA isolation and cDNA synthesis were performed similar to
(Popov et al., 2011): RNA was extracted with RNeasy Mini
Kit (Qiagen, Gemany) and 1 μg total RNA was used for
cDNA synthesis with AMV First-Strand cDNA Synthesis Kit
following the manufacturer’s instructions (Thermo scientific,
USA). Quantitative PCR analysis for the complete ephrin family
expression in human Y- and A-TSPC was done with RealTime
Ready Custom panel array (Roche, Germany). Each array
consisted of 9 EphA (1–8 and 10), 5 EphB (1–4 and 6), 5 EFNA
(1–5), and 3 EFNB (1–3) genes and three housekeeping genes
GAPDH, HPRT, and SDHA. For calculation of the relative gene
expression, ratio between targeted gene and GAPDH was made.
Data consisted of three independent repeats with all three Y- and
A-TSPC donors (n = 9).
Cytochemistry
Y- and A-TSPC plated and cultured on 20 μg/ml collagen
1-coated glass slides (BD Bioscience, USA) for 48 h were
fixed with 4% paraformaldehyde (Merck, Germany) or 7%
formalin/PHEM (6 mM PIPES, 25 mM HEPES, 10 mM EGTA,
3 mM MgCl2, pH 6.1, all Sigma–Aldrich) solutions. Then, cells
were permeabilized with 0.1% Triton X100 (Sigma–Aldrich)
and blocked with 3% BSA (Millipore, USA). Primary antibodies
against EphA4 (Abnova, Germany), EphB2 (Biomol, Germany),
EphB4 (Thermo scientific), EFNB1 and EFNB2 (both Sigma–
Aldrich) were applied overnight at 4◦C. Next, secondary Alexa
Flour 488-conjugated antibodies and DAPI were used (all
Life technologies). For negative control, cell-seeded slides were
incubated only with the secondary antibody and DAPI. For
F-actin staining, formalin/PHEM fixed cells were incubated
with phalloidin-AF546 (Life technologies) for 40 min at room
temperature. Photomicrographs were taken with Axiocam MRm
camera on AxiovertS100 microscope (Carl Zeiss, Germany).
Staining experiments were repeated two independent times for
all three Y- and A-TSPC donors (n = 6).
Western Blot Analysis
Total protein from Y- and A-TSPC (clustered EphA4 and
EphB2, and Fc-control) was isolated with RIPA-buffer (0.1%
SDS, 1% Na-DOC, 1% Triton X-100, 50mM Tris-HCl pH8.2,
150mM NaCl, 10mM EDTA, 20mM NaF, 1mM Na3VO4)
supplemented with complete protease inhibitors (Roche).
Proteins (20 μg) were separated on SDS gels, transferred onto
PVDF membrane and blocked with 5% skim milk (Merck) for
1 h at room temperature. Primary antibodies against human
EphA4 (Abnova), EphB2 (Biomol), EphB4 (Thermo scientific),
EFNB1 and EFNB2 (both Sigma–Aldrich); phospho-FAK
(Thermo scientific), total FAK, total and phospho-ERK1/2;
total and phospho-Akt; total and phospho-p38; total and
phospho-Jnk (all Cell Signaling, USA), and GAPDH (Merck)
were applied overnight at 4◦C. Then, membranes were
incubated with corresponding secondary HRP-conjugated
antibodies (Cell Signaling) for 1 h at room temperature
and consequently with ECL solution (GE Healthcare, USA).
Photomicrographs were taken on ImageQuant LAS 4000
mini (GE Healthcare) as band intensities were quantified
with ImageProPlus4 software program (Media Cybernetics,
USA). Western blot experiments were preformed two
independent times with all three Y- and A-TSPC donors
(n = 6).
Self-Renewal Analysis
Tendon stem/progenitor cell self-renewal was assessed with
WST-1 proliferation and colony forming unit (CFU) assays
as described in (Kohler et al., 2013). For cell proliferation,
3 × 103 cells/ cm2 of Y- and A-TSPC (EphA4-Fc, EphB2-
Fc, and Fc-control) were plated in complete culture medium
containing 0.2% FBS, with or without clustered EphA4 and
EphB2 protein for 7 days. Thereafter, WST-1 reagent (Roche)
was applied for 4 h and optical density (OD) was measured
at 420 and 620 nm using a Microtiter Reader (Thermo
Scientific). Cell proliferation was calculated in percentage to
Y-TSPC. WST-1 assay was reproduced three independent
times with all Y- and A-TSPC donors, as each experiment
was done in triplicates (n = 9). For the CFU assay, 20
cells/ cm2 of Y-, and A-TSPC (EphA4-Fc, EphB2-Fc, and Fc-
control) were plated in 10 cm culture dishes for 12 days in
complete media supplemented with or without EphA4 and
EphB2 clustered protein. Then, cell colonies were visualized
with 0.5% crystal violet/methanol staining and counted. CFU
efficiency was estimated as percentage of counted colonies to the
number of plated cells. CFU experiment was performed three
independent times of all Y- and A-TSPC donors in duplicates
(n = 9).
Migration Analysis
Migration analysis was performed similarly to (Kohler et al.,
2013) using Axiocam ICc3 camera mounted on Axiovert S100
inverted microscope (Carl Zeiss) equipped with biochamber
(PeCon, Germany) providing stable culture conditions. For
random migration, 1.5 × 103 cells/ cm2 of Y- and A-TSPC
(EphA4-Fc, EphB2-Fc, and Fc-control) were seeded in 6-well
plates and incubated for 2 h prior imaging. Time-lapse was
performed with four frames per h for 2 days. The image
data was extracted with AxioVisionLE software (Carl Zeiss)
and individual cell tracks were analyzed with ImageJ V1.48
software. Random migration was expressed by calculation of
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the forward migration index [FMI; the ratio of the vector
length to the migratory starting point based on (Sip et al.,
2014)]. Results of random TSPC migration consist of three
independent repeats with all Y- and A-TSPC donors (n = 9;
total of 150 tracks per donor type). For the scratch assay,
1 × 104 cells/ cm2 of Y- and A-TSPC (EphA4-Fc, EphB2-
Fc, and Fc-control) were plated in 6-well dishes and let to
form confluent monolayers for 2 days. Prior imaging, the layers
were scratched multiple times. Time-lapse was performed with
four frames per h for 3 days. The initial scratch length and
time needed for gap bridging were measured and used for
calculation of cell velocity. The scratch assay was reproduced
three independent times for each donor group as each experiment
was done in triplicates (n = 9, 36 scratches per donor
type).
Quantification of Cell Area and Actin
Dynamics
Quantification of Y- and A-TSPC (EphA4-Fc, EphB2-Fc, and
Fc-control) cell area was obtained from F-actin images by
measuring 50 cells from each donor with the polygonal tool
of the ImageProPlus4 software (Media Cybernetics). Actin
dynamics of Y- and A-TSPC (EphA4-Fc, EphB2-Fc, and Fc-
control) was analyzed by latrunculin A experiment, carried
out as described in (Kohler et al., 2013). Latrunculin A
inhibits actin polymerization by sequesteringmonomeric G-actin
and thereby disrupts the turnover of actin filaments. In
brief, the four different TSPC groups, Y- and A-TSPC with
EphA4-Fc, EphB2-Fc, and Fc-control, (5.5 × 103 cells/cm2)
were grown in 96 well plates and pre-cultured for 48 h.
Then, cells were treated with 0.4 μM latrunculin A (Sigma–
Aldrich), fixed at different time intervals (0, 2, 5, 8, 10,
20, 30, and 60 min), stained with 0.6 μM phalloidin-546
(Thermo Scientific) and fluorescence signals were recorded
at 573 nm using a SAFIRE2 microplate reader (Tecan,
Germany). In each group, F-actin content at time point 0 was
set to 100%. Latrunculin A analyses were reproduced three
independent times for all Y- and A-TSPC donors in triplicates
(n = 9).
Statistical Analysis
In the study 3 Y-TSPC and 3 A-TSPC representative lines were
used in all experiments. The quantitative data was generated
out of all three different donors per group and furthermore
each donor was used in 3 (n = 9) or 2 (n = 6) independent
experiments. Statistical evaluation was performed using the
GraphPrism software (GraphPad, La Jolla, CA, USA). Final
graphs and bar charts show mean values ± SD of two or
three independent experiments for the donor group. Within
each of the independent experimental repeats, the individual
donors were represented in triplicates, however, the replicates
were calculated as mean value for the donor. Unpaired t-test
was used for two group analysis and Tukey’s one-way ANOVA
was applied for multi group statistical testing. A p-value < 0.05
was considered statistically significant (∗p < 0.05; ∗∗p < 0.01,
∗∗∗p < 0.001).
RESULTS
Expression Levels of Several Ephrin
Members were Significantly
Downregulated in A-TSPC
We first compared the whole ephrin family expression profile
in Y- and A-TSPC by using quantitative PCR (Figure 1A).
Our results demonstrated that in comparison to Y-TSPC,
A-TSPC expressed significantly lower levels of EphA4 (3.5
folds), EphB2 (7 folds), and EphB4 (7 folds) receptors, and
EFNB1 (1.3 folds) ligand, but increased levels of EFNB2 (2.3
folds). These expression changes were further verified on protein
level by immunocytochemical staining (Figure 1B) and western
blotting (Figure 1C), which confirmed the downregulation of
EphA4, EphB2, EphB4, and EFNB1, and upregulation of EFNB2
expression in A-TSPC. Taken together, our novel data evidently
showed that during tendon aging and degeneration, EphA4,
EphB2, EphB4, and EFNB1 mRNA and protein expression levels
are significantly downregulated in TSPC.
Analysis of Activation of Key Cellular
Kinases in A-TSPC Selects EphA4 and
EphB2 as Main Candidates of Interest
In order to investigate the importance of EphA4, EphB2,
EphB4, and EFNB1 downregulation for TSPC aging and
degeneration, we next designed rescue experiments based
using established protocols (refer to Materials and Methods).
We first stimulated externally A-TSPC with EphA4, EphB2,
EphB4, and EFNB1 clustered proteins and then analyzed
the activation of their downstream signaling in the cells
(Figure 2A). As mentioned in the introduction, the main
downstream effectors of ephrin-mediated signaling are the
cellular kinases FAK, ERK, Akt, JNK, and p38 (Figure 2B and
Supplementary Figure S1). Direct comparison in-between basal
kinase activities demonstrated that ERK andAkt phosphorylation
was significantly elevated in A-TSPC. EphA4-Fc stimulation
of A-TSPC led to increased FAK and JNK activity and
more importantly, to reduced ERK phosphorylation to levels
comparable to Y-TSPC. Stimulation with EphB2-Fc resulted in
significantly increased phosphorylation levels of JNK and p38
kinases in A-TSPC. These results suggests that EphA4 and
EphB2 signaling overlaps mainly in activation of JNK kinase;
however, these both ephrins demonstrated clear difference in
ERK, FAK, and p38 activation. In comparison to EphA4 and
EphB2, activation with EphB4-Fc and EFNB1-Fc did not show
robust effect on A-TSPC kinase activity. Therefore, in our next
experiments, we continued only with EphA4-Fc and EphB2-Fc,
and investigated their effect on A-TSPC self-renewal, migration
and actin dynamics (refer to Figure 2C).
EphA4-Fc Signaling, but not EphB2-Fc,
Positively Affects A-TSPC Self-Renewal
We investigated the effect of EphA4-Fc and EphB2-Fc on TSPC
self-renewability by performing short-term cell proliferation
(WST-1; Figure 3A) and colony-forming units (CFU) assays
Frontiers in Aging Neuroscience | www.frontiersin.org 4 January 2016 | Volume 7 | Article 246
Popov et al. TSPC Age-Related Ephrin Changes
FIGURE 1 | Ephrin expression in tendon stem/progenitor cells (TSPCs). (A) Comparison between Y- and A-TSPC basal ephrin family expression by
quantitative PCR array. Data consists of three independent repeats with all three Y-and A-TSPC donors (n = 9, ∗∗∗p ≤ 0.001). (B) Cytochemical and (C) western blot
protein analysis for EphA4, EphB2, EphB4, EFNB1, and EFNB2 in Y- and A-TSPC (n = 6; full blot shown in Supplementary Figure S1). Representative images;
bars = 50 μm.
(Figure 3B). A-TSPC exhibited slower proliferation rate and
clonogenic ability. Interestingly, when treated with clustered
EphA4-Fc A-TSPC proliferation significantly increased to levels
comparable to Y-TSPC, while supplementation with EphB2-
Fc had no effect. The addition of EphA4-Fc to A-TSPC had
tendency to elevate their CFU numbers; however, it did not lead
to significant change (p = 0.06). In comparison to EphA4-Fc,
the second candidate EphB2-Fc showed a significant difference
as treatment with this ephrin inhibited the A-TSPC clonogenic
potential with approximately 12-folds, thus suggesting that
EphA4- and EphB2-mediated reverse signaling cascades diverge
in their cellular functions.
EphA4-Fc and EphB2-Fc Restore the
Migration Deficit of A-TSPC
In order to determine whether EphA4-Fc and EphB4-Fc have
positive influence, we next performed random migration and
scratch assays (Figure 4). The random migration, represented
by FMI confirmed that A-TSCP are indeed less migratory than
Y-TSPC and showed that the addition of both EphA4-Fc and
EphB2-Fc enhances their cell motility (Figure 4A). Moreover,
quantification of accumulated length and velocity clearly
indicated that the observed effect is significant (Figure 4B).
However, in-between both types of receptors, EphA4 was more
potent inducer of TSPC migration. This finding was further
validated by scratch assay (Figures 4C,D) revealing that EphA4-
Fc A-TSPC closed first the distance between the two fronts
(13.2 ± 0.9 h), followed by Y-TSPC (15.4 ± 1.3 h), EphB2-
Fc A-TSPC (17.4 ± 0.5 h), and last A-TSPC (20.9 ± 0.6 h)
(Figure 4C). In summary, we can report for the first time that
activation of EphA4 or EphB2-dependent reverse signaling can
rescue the migration deficit of A-TSPC, furthermore, EphA4-Fc
stimulated A-TSPC performed even better than Y-TSPC.
EphA4-Fc and EphB2-Fc Improve
A-TSPC Actin Dynamics
Finally, we performed phalloidin staining for F-actin and
compared the actin filament dynamics in the four TSPC groups
by treating them with latrunculin A in a time-dependent
manner. First, we investigated changes in cell area and we
found neither EphA4-Fc nor EphB2-Fc affected the cell area
habituated by A-TSPC (Figure 5A). In contrast, our latrunculin
a analyses, performed 48 h after A-TSPC treatment with
the corresponding ephrins, indicated reduced F-actin content
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FIGURE 2 | Experimental design and western blot analysis of key cellular kinases in TSPC. (A) Schematic presentation of A-TSPC stimulation with
clustered ephrins. (B) Western blot analysis of phosphorylated and total FAK, ERK, Akt, JNK, and p38 kinases in Y-TSPC and EphA4-Fc, EphB2-Fc, EphB4-Fc,
EFNB1-Fc, and control-Fc A-TSPC. Data consists of two independent repeats with all three Y-and A-TSPC donors (n = 6, ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001).
(C) Experimental study design.
FIGURE 3 | Self-renewal potential of EphA4-Fc and EphB2-Fc A-TSPC. (A) WST-1 proliferation and (B) CFU analysis of Y-TSCP, EphA4-Fc, EphB2-Fc, and
control-Fc A-TSPC. Data consists of three independent repeats with all three Y-and A-TSPC donors (n = 9, ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001).
visualized by phalloidin staining at 60 min (Figure 5B).
Quantification of time-dependent F-actin decrease and curve
declination angle (Figure 5C) showed that both EphA4-Fc and
EphB2-Fc significantly improved the actin turnover of A-TSPC
to levels comparable to Y-TSPC. Figure 5D represents the basal
levels of F-actin in the four different groups prior the latrunculin
A treatment (upper graph, time point 0 min). However, the
EphA4-Fc- or EphB2-Fc-treated A-TSPC, when challenged with
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FIGURE 4 | Migration of EphA4-Fc and EphB2-Fc A-TSPC. (A) Representative images of random migration (dash lines show ecludian distance) and calculation
of forward migration index (FMI). Bars = 100 μm. (B) Quantification of random migration (distance and velocity) (n = 9, total of 150 tracks per donor type).
(C) Representative scratch assay of Y-TSCP, EphA4-Fc, EphB2-Fc, and control-Fc A-TSPC. Bars = 200 μm. (D) Estimation of scratch bridging time and cell
velocity (n = 9, total of 36 scratches per donor type, ∗p < 0.05; ∗∗p < 0.01, ∗∗∗p < 0.001).
FIGURE 5 | Actin dynamics of EphA4-Fc and EphB2-Fc A-TSPC. (A) Representative images of F-actin staining and quantification of the cell area of Y-TSPC,
EphA4-Fc, EphB2-Fc, and control-Fc A-TSPC (n = 9, total of 50 cells per donor). (B) Representative images of Y-TSPC, EphA4-Fc, EphB2-Fc, and control-Fc
A-TSPC at seven time points during latrunculin A treatment. (C) Quantification of actin filament dynamics in a time-dependent manner and curve declination angle.
(D) Total actin content at the beginning (0 min) and at the end (60 min) of the latrunculin A experiment (n = 9, ∗p < 0.05; ∗∗p < 0.01).
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LatA, were able to normalize their F-actin content to levels similar
to Y-TSPC (lower graph, time point 60 min).
In summary, our novel findings demonstrate that activation
of EphA4- and EphB2-dependent reverse signaling augments the
motility and actin turnover of A-TSPC, but only EphA4 rescues
their cell proliferation deficit.
DISCUSSION
In the current study, we report for the first time that A-TSCP
have dysregulated cell–cell interactions mediated by the ephrin
family. By comparing Y- to A-TPSC we found that the expression
of several ephrin members is significantly changed. Next, by
carefully examining the role of two main candidates, namely
the receptors EphA4 and EphB2, we could demonstrate that by
activating their reverse signaling, via external delivery of the
clustered receptors, we can normalize several of the A-TSCP
deficits.
The importance of ephrin receptor-ligand interactions has
increasingly been recognized not only in the neuronal system
(Du et al., 2007) and cancer (Guo et al., 2006), but also in
musculoskeletal tissues such as bone (Zhao et al., 2006; Cheng
et al., 2012; Stiffel et al., 2014) and muscle (Swartz et al.,
2001; Stark et al., 2011). As mentioned in the introduction,
only one paper so far reported on the expression of EphA4
during tendon morphogenesis in chick limbs (D’Souza and Patel,
1999). Recent study focusing on periodontal ligament fibroblasts
and osteoblasts showed important strain-dependent involvement
of EphB4/EFNB2 in modulating osteogenesis during tooth
movement (Diercke et al., 2011). Hence, to our knowledge
we are the first to report on the ephrin expression profile
in TSPC. Among the 15 Eph receptors and the nine EFN
ligands found in human, TSPC expressed predominantly four
receptors and two ligands. Furthermore, upon tendon aging
and degeneration, EphA4, EphB2, and EphB4 and EFNB1
ligand were significantly downregulated, while EFNB2 was
upregulated, both on mRNA and protein levels. After initial
screening of the downregulated ephrin candidates, we decided
to focus in the main part of our study on rescue experiments
with EphA4-Fc and EphB2-Fc proteins and to investigate their
effect on the self-renewal, migration and actin dynamics of
A-TSPC.
We started with self-renewal analyses. Previous literature
on different ephrin members has suggested strong cell-specific
effects; for example, EphA7/EFNA2 negatively regulates the
cell proliferation of adult neural progenitor in the olfactory
bulb (Holmberg et al., 2005), whereas EphB2-forward signaling
stimulates intestine progenitor self-renewal (Genander et al.,
2009). When we examined TSPC self-renewal by performing
short-term cell proliferation and CFU assays, we found that
EphA4-Fc, but not EphB2, can rescue the age-associated drop
of proliferation as well as demonstrated a tendency to elevate
A-TSPC clonogenicity, a finding which can be further explored
and optimized in follow up studies. Our investigation of the
downstream effectors revealed that both clustered proteins
trigger activation of JNK kinase, however, EphA4-Fc also elevates
the FAK phosphorylation, while EphB2 p38 phosphorylation.
Hence, we speculate that this divergence in their signaling
cascades might be contributing for the different effect on
A-TSPC self-renewal; however, follow up studies will be
necessary to investigate in great details the exact molecular
mechanisms.
Next, we focused on investigating the effect of EphA4-
Fc and EphB2-Fc on A-TSPC migration and actin turnover.
We have described the age-related marked reduction in cell
motility and actin dynamics of TSPC in (Kohler et al., 2013);
here, we report for the first time that both EphA4-Fc or
EphB2-Fc can significantly increase A-TSPC random migration
and wound healing to rates similar to, and in the case of
EphA4-Fc even better than, that of Y-TSPC. This novel data
is in line with several studies claiming a positive effect of
different ephrin family members on stem or progenitor cell
migration (Arthur et al., 2011; Goichberg et al., 2011; Li
and Johnson, 2013). Actin cytoskeletal dynamics are pivotal
for cell migration (Rottner and Stradal, 2011), therefore by
implementing latrunculin A experiments and F-actin staining
we compared the cell shapes, F-actin content and the kinetic,
and speed of actin filament turnover in Y-TSPC versus A-TSPC
with or without EphA4-Fc and EphB2-Fc. Our results clearly
demonstrated that activation of EphA4 or EphB2 reverse
signaling in A-TSPC significantly improves their actin turnover
to a mode similar to Y-TSPC. However, the A-TPSC shape and
F-actin amount at the start point of the experiments were not
affected by the addition of EphA4-Fc and EphB2-Fc, a finding
that is different to other reports showing a regulatory function
of certain ephrins on cell shape and spreading (Stokowski
et al., 2007; Yamazaki et al., 2009; Arthur et al., 2011). It
has been proposed that ephrins can affect cell migration by
interfering with actin cytoskeleton dynamics via modulated
GTPase activity (Marston et al., 2003; Buricchi et al., 2007;
Takeuchi et al., 2015). A current limitation of our study
is the lack of specification of EphA4 and EphB2 reverse
partners in TSPC. Based on the expression analyses, we can
speculate that the major ligands are EFNB1 or EFNB2, however,
the identification of the exact EphA4 or EphB2-dependent
reverse signaling pathway, and the possible involvement of
GTPases, remain as challenges to be addressed in future
research.
Taken together, our novel data suggests that decreased
expression of the ephrin receptors EphA4 and EphB2 during
tendon aging and degeneration limits the establishment of
appropriate cell–cell interactions between TSPC and significantly
diminished their proliferation, motility and actin turnover. We
found that delivery of EphA4-Fc or EphB2-Fc to A-TSPC can
successfully normalize several of the key aspects of their age-
related phenotype and that in-between the two the EphA4-Fc
is the more dominant. We could propose that dysregulation
in EphA4-trigered bi-directional signaling may contribute to
the inferior and delayed tendon healing common for aged
individuals, which will be the focus for upcoming investigation.
Hence, we believe that our pioneering study provides important
and novel insight into the complex nature of tendon aging and
degeneration.
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FIGURE S1 | Complete western blot image. Aliquots of equal amounts of
protein from three Y-TSPC and A-TSPC treated with EphA4-, EphB2-, EphB4-,
and EFNB1-Fc proteins were loaded onto the same western blot membranes,
which were first probed for the expression levels of phospho-FAK, ERK, AKT, Jnk,
and p38. Next, the same membranes were stripped and probed for the
corresponding total-FAK, ERK, AKT, Jnk, and p38. Comparable protein loading
was validated with anti-GAPDH antibody. Complete western blot image
corresponding to the phosphor-lanes in the inset B of Figure 2. The same
procedure was performed for another two A-TSPC donors. Abbreviations: MW –
positions of the molecular weight protein standard; 1–3, different Y-TSPC donors;
A4, EphA4-Fc-; B2, EphB2-Fc-; B4, EphB4-Fc; B1, EFNB1-Fc-treated, and “−”,
non-treated A-TSPC.
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